TY - JOUR
T1 - Mecamylamine selectively blocks nicotinic receptors on vasomotor sympathetic C neurons
AU - Shen, Wei Xing
AU - Horn, John P.
N1 - Funding Information:
This work was supported by a grant-in-aid from the American Heart Association, Pennsylvania Affiliate.
PY - 1998/3/30
Y1 - 1998/3/30
N2 - Mecamylamine differentially blocked fast nicotinic transmission in two functional subsets of sympathetic neurons within lumbar paravertebral ganglia of the bullfrog. EC50s for inhibition of postsynaptic compound action potentials were 27.3 ± 2.5 μM in the secretomotor B system and 5.7 ± 0.7 μM in the vasomotor C system. This 5.2:1 selectivity is 2.6 times greater than observed previously with D-tubocurarine, a nonselective blocker of nicotinic receptors, and it indicates that mecamylamine preferentially, interacts with nicotinic receptors on sympathetic C neurons. We tested this by analyzing the effect of mecamylamine upon synaptic currents. In both cell types, the drug produced a qualitatively similar picture of open-channel blockade. It reduced EPSC amplitude, speeded EPSC decay, and became more effective with membrane hyperpolarization and repetitive activity. Despite these similarities, 8 μM mecamylamine reduced EPSC amplitude to a greater extent in C neurons, and the rate constant for drug binding to open channels was 4.4 times greater in B cells, irrespective of membrane potential. This implies that the unblocking rate for mecamylamine is much slower in C cells than B cells, and it shows that the drug recognizes a structural difference between nicotinic receptors on these two populations of sympathetic neurons.
AB - Mecamylamine differentially blocked fast nicotinic transmission in two functional subsets of sympathetic neurons within lumbar paravertebral ganglia of the bullfrog. EC50s for inhibition of postsynaptic compound action potentials were 27.3 ± 2.5 μM in the secretomotor B system and 5.7 ± 0.7 μM in the vasomotor C system. This 5.2:1 selectivity is 2.6 times greater than observed previously with D-tubocurarine, a nonselective blocker of nicotinic receptors, and it indicates that mecamylamine preferentially, interacts with nicotinic receptors on sympathetic C neurons. We tested this by analyzing the effect of mecamylamine upon synaptic currents. In both cell types, the drug produced a qualitatively similar picture of open-channel blockade. It reduced EPSC amplitude, speeded EPSC decay, and became more effective with membrane hyperpolarization and repetitive activity. Despite these similarities, 8 μM mecamylamine reduced EPSC amplitude to a greater extent in C neurons, and the rate constant for drug binding to open channels was 4.4 times greater in B cells, irrespective of membrane potential. This implies that the unblocking rate for mecamylamine is much slower in C cells than B cells, and it shows that the drug recognizes a structural difference between nicotinic receptors on these two populations of sympathetic neurons.
KW - Blood pressure
KW - Bullfrog sympathetic ganglia
KW - Neuronal nicotinic receptors
KW - Open-channel block
UR - http://www.scopus.com/inward/record.url?scp=0032579842&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032579842&partnerID=8YFLogxK
U2 - 10.1016/S0006-8993(97)01520-5
DO - 10.1016/S0006-8993(97)01520-5
M3 - Article
C2 - 9554976
AN - SCOPUS:0032579842
SN - 0006-8993
VL - 788
SP - 118
EP - 124
JO - Brain Research
JF - Brain Research
IS - 1-2
ER -